Hub genes including FANCI, POSTN, IFIH1, ZMYND10, PACRG and POU2AF1 might serve as novel biomarkers for precision diagnosis and providing medical treatment for patient with NPC. The gene discussed is IFIH1; the disease is nasopharyngeal carcinoma.